Glaukos Announces Participation in Upcoming Investor Conferences
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, will participate in several upcoming investor conferences including the Stifel Virtual Ophthalmology Forum and the William Blair 46th Annual Growth Stock Conference.
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences: Stifel Virtual Ophthalmology Forum on Tuesday, May 26, 2026, at 1:30 p.m. ET William Blair 46th Annual Growth Stock Conference on Tuesday, June 2, 2026, at